The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Poidster, you can see all the stats here:
https://www.worldometers.info/coronavirus/
Not ideal viewing on an iPhone though, provides and interesting perspective.
The mental thing is the government have allowed themselves to be pressured by the travel industry (stop putting extra costs onto travellers), yet Heathrow have today raised their fees by 50 odd percent. Comical.
I don’t understand how they’ve used a new formula, as far as I’m concerned there’s only one.
1000 people do a LFT and a PCR to analyse the LFT result, that is the only sure fire way of assessing, not making up formulas with a one size fits all policy. It’s like saying all cars produce x amount of Co2, we know innova are ****e yet people will now think they’re 80% effective.
https://twitter.com/big_morgy/status/1448274294023335942?s=21
Get voting
Kaeren and airlineboy, agreed; anything over a certain value should be RNSd, especially with the MCAP so low. If you win a new contract that’s expected to be 3-5% of you declared yearly revenue then it would help with sentiment and therefore value.
https://link.springer.com/article/10.1007/s10654-021-00808-7
“The sole reliance on vaccination as a primary strategy to mitigate COVID-19 and its adverse consequences needs to be re-examined, especially considering the Delta (B.1.617.2) variant and the likelihood of future variants. Other pharmacological and non-pharmacological interventions may need to be put in place alongside increasing vaccination rates. Such course correction, especially with regards to the policy narrative, becomes paramount with emerging scientific evidence on real world effectiveness of the vaccines.
For instance, in a report released from the Ministry of Health in Israel, the effectiveness of 2 doses of the BNT162b2 (Pfizer-BioNTech) vaccine against preventing COVID-19 infection was reported to be 39%.”
I personally believe COVID-19 revenue will be high for a lot longer than the next 18 months.
Kaeren, duncan never voiced these opinions until about a week or 2 about, either he was very clever and sat there pretending he was invested or recently sold out and now has a vendetta. He left the group 2 weeks ago and surfaced on here.
It’s barely worse replying to you, you act as if you have inside information that the company is planning a raise (we know you don’t). There’s no requirement for a raise, they have over 10 x more cash in the bank than most AIM companies, some with a higher MCAP. The accounts have detailed what the maximum liability for DHSC is, this doesn’t leave the company poor. They are also still printing cash each day.
Why don’t you move on with your personal vendetta, the agenda is obvious. Green bin.
Dunc, why are you so obsessed with this company, it’s pretty obvious you have sold out. You had an agenda in the telegram group and you have an agenda here.
Your logic of the BoD driving the price down to then issue a discounted placing is beyond me. The only time they would issue a place is in the event they want to do a large M and A.
How do you know who to give those treatments to? Testing, I can’t see hospital testing ever going away. You need to test individuals on arrival to see how best to treat them. The entire population won’t be given a drug or get it over the counter.
https://www.**********.co.uk/rns/announcement/1348347b-58a5-4c8a-852f-1bf2779216b3/
Ironic the concern about rising cases in the UK, the COVID winter plan etc, yet the government talk about stopping PCR for double vaccinated passengers returning:
https://www.dailymail.co.uk/news/article-9981099/End-PCR-travel-tests-Double-jabbed-travellers-no-longer-expensive-Covid-tests.html
What on Earth is wrong with this government, it’s pretty fu**ing obvious being vaccinated doesn’t stop transmission or carrying the virus. Furthermore that means no genomic sequencing of variants entering into the country.